ANALYSIS OF THE DAILY VARIATION IN BLOOD-PRESSURE AND PHARMACOKINETICS AFTER SINGLE OR REPEATED ADMINISTRATION OF CLENTIAZEM TO PATIENTS WITH ESSENTIAL-HYPERTENSION

被引:0
作者
SUZUKI, S
MORI, M
KUSANO, S
机构
来源
ARZNEIMITTEL-FORSCHUNG/DRUG RESEARCH | 1992年 / 42-1卷 / 04期
关键词
ANTIHYPERTENSIVES; CALCIUM ANTAGONISTS; CAS; 96125-53-0; CLENTIAZEM; CLINICAL PHARMACOKINETICS; HYPERTENSION; DAILY VARIATION; ESSENTIAL; TA-3090;
D O I
暂无
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Clentiazem (TA-3090, CAS 96125-53-0), a new benzothiazepine Ca++ antagonist, was orally administered to inpatients with essential hypertension at a dose of 30 mg at 8:00 a.m. once (n = 5) or daily for 2 weeks (n = 22). After administration of the medication, the daily variations in blood pressure and pulse rate were monitored using a portable blood pressure recorder, and plasma concentrations of clentiazem were determined by HPLC. 1. In the single administration study an antihypertensive effect was observed between 4 and 12 h with a peak approximately 8 h after administration. After the single dose, the diurnal pulse rate was higher than the pretreatment level, but it was not correlated with the antihypertensive effect. 2. In the repeated administration study, both the systolic and diastolic blood pressures showed significant decreases after administration throughout the day (p < 0.01). The nocturnal antihypertensive effect was weaker than the diurnal effect, and the minimum decrease/maximum decrease ratio in a day was 0.52 for both systolic and diastolic pressures. The pulse rate decreased slightly during certain time intervals after administration (p < 0.01 or p < 0.05), but those were slight changes. 3. As to the pharmacokinetic profile clentiazem showed a long-lasting plasma level, the t(max) was 6.8 +/- 1.1 h for the single treatment and 6.9 +/- 1.6 h for the repeated treatment; the C(max) was 16.9 +/- 6.1 ng/ml and 19.3 +/- 8.8 ng/ml, respectively; and the t(1/2) was 6.6 +/- 1.5 h and 12.5 +/- 5.4 h, respectively. The plasma level profiles, for single and repeated administrations were similar. 4. Headache and nausea, and increases in GOT and GPT occurred transiently during the period of study. It can be concluded from these data that clentiazem given once a day at a dose of 30 mg exerted a sufficient stable antihypertensive effect that persisted for 24 h.
引用
收藏
页码:533 / 539
页数:7
相关论文
共 23 条
[1]  
BEVAN A, 1966, P PHYSL, pP3
[2]  
ETO A, 1980, CLIN REPORT BASIC CL, V14, P3082
[3]  
GOULD BA, 1983, HYPERTENSION, V5, P91
[4]  
KAINUMA T, 1991, J CLIN THERAP MED, V7, P2149
[5]   LABILE HYPERTENSION - A FAULTY CONCEPT - THE FRAMINGHAM-STUDY [J].
KANNEL, WB ;
SORLIE, P ;
GORDON, T .
CIRCULATION, 1980, 61 (06) :1183-1187
[6]   EFFICACY AND SAFETY OF CLENTIAZEM IN PATIENTS WITH ESSENTIAL-HYPERTENSION - RESULTS OF AN EARLY PILOT TEST [J].
KAWAKITA, S ;
KINOSHITA, M ;
ISHIKAWA, H ;
KAGOSHIMA, T ;
KATORI, R ;
ISHIKAWA, K ;
HIROTA, Y .
CLINICAL CARDIOLOGY, 1991, 14 (01) :53-60
[7]  
KIKKAWA K, 1988, ARZNEIMITTEL-FORSCH, V38-1, P526
[8]  
LANNART H, 1984, NITRENDIPINE, P423
[9]   PROPRANOLOL LA AND AMBULATORY BLOOD-PRESSURE [J].
MANN, S ;
CRAIG, MWM ;
BALASUBRAMANIAN, V ;
RAFTERY, EB .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1980, 10 (05) :443-447
[10]   DIURNAL-VARIATION IN OCCURRENCE OF STROKES [J].
MARSHALL, J .
STROKE, 1977, 8 (02) :230-231